Ryanodine Receptor Stabilization Therapy Suppresses Ca2+- Based Arrhythmias in a Novel Model of Metabolic HFpEF
A. D. Kaplan, L. Boyman, C. W. Ward, W. J. Lederer, M. Greiser
This study develops a novel HFpEF model and shows that ryanodine receptor stabilization with dantrolene prevents stress-induced ventricular tachycardia in metabolic HFpEF.
bioRxiv · Jun 21, 2023Physiology